Radiation Exposure to the Nuclear Medicine personnel during preparation and handling of 213Bi- radiopharmaceuticals.
Background: Due to excellent ability of α-particles to transfer the high amount of energy over a short tissue range, targeted α-therapy (TAT) has been attracting rising number of nuclear medicine centers. In this study, we estimated the radiation exposure to the occupational worker with pocket dosimeter during the handling of α-emitter: Bi-213, used for targeted α-therapy (TAT) of neuroendocrine tumors (NET) and castration resistant prostate cancer (CRPC) patients. The dose rates from the patients at different distances and at different time points after therapeutic injection were also evaluated. Materials and Methods: This prospective study was done in the Department of Nuclear Medicine at Fortis Memorial Research Institute, Gurgaon, India. A total of twelve patients with NET or CRPC were enrolled for 213Bi-DOTATOC or 213Bi-PSMA therapy, respectively. Each patient received 2-3 intravenous injections of 213Bi-peptide, 266 - 362MBq (7.2 - 9.8mCi) in a single cycle over 2-3 days. Radiation exposure to nuclear medicine personnel at chest and extremity levels were assessed for different tasks such as elution, dispensing, injecting and, collecting blood samples etc. Radiation levels were measured at a distance of 1cm and at 1m from the patients immediately after, and at 1, 2, and 4h after the administration of 213Bi-peptide. Results: The effective external doses incurred by a radiopharmacist during synthesis, by physicians during injection, by technologists during imaging and nurses during sample collection at the chest level were measured using the pocket dosimeter and were found to be in the range of 2-7 µSv/procedure. The extremity doses were in the range of 1-14 µSv/procedure. The dose rate at 1m from 213Bi-radiopharmaceutical injected patients immediately after therapy was in the range of 0.02-0.03µSv/MBq.h. Conclusion: The study shows that the use of 213Bi-PSMA/DOTATOC for the therapy of CRPC and NET, respectively, has been convenient, safe and straightforward. The external radiation doses to the occupational workers involved in different procedures were far below the dose limits prescribed by the Regulatory Authority (20mSv/yr). The dose rates from the treated patients showed no detrimental effect on public and environment.